Amarantus Bioscience Holdings, Inc. Commercialization On-Track for 2014: Updating LymPro Test(R) Progress - kcentv.com - KCEN HD - Waco, Temple, and Killeen

Amarantus Bioscience Holdings, Inc. Commercialization On-Track for 2014: Updating LymPro Test(R) Progress

Posted: Updated:

SAN FRANCISCO, CA / March 31, 2014 / Amarantus Bioscience Holdings, Inc. (OTCQB: AMBS) today published a new blog post on The Chairman’s Blog, written by the Company’s CEO, Mr. Gerald Commissiong. TheChairmansBlog.com is an exclusive online media publication that enables key executive officers a unique platform to share insights about their company and industry trends.

In his blog, Mr. Commissiong outlines Amarantus’ recent achievement of key milestones that the company believes will add significant value in the commercialization and development of the LymPro test (R) for Alzheimer’s. “As we prepare for LymPro’s commercialization in the second half of 2014, we believe it is critical to properly position LymPro within the scientific community, the investment community and the general population as THE commercially-validated blood test as we prepare for product launch,” states Mr. Commissiong. Read the full blog post from Mr. Gerald Commissiong on TheChairmansBlog.com (http://www.thechairmansblog.com/amarantus-bioscience/gerald-commissiong/commercialization-track-2014-updating-lympro-test-progress/).

About Amarantus

Amarantus is a biotechnology company developing treatments and diagnostics for diseases associated with neurodegeneration and protein misfolding-related apoptosis. The Company has licensed Eltoprazine (“Eltoprazine”), a phase 2b ready indication for Parkinson’s Levodopa induced dyskinesia and Adult ADHD. The Company has an exclusive worldwide license to the Lymphocyte Proliferation test (“LymPro Test®”) for Alzheimer’s disease and owns the intellectual property rights to a therapeutic protein known as Mesencephalic-Astrocyte-derived Neurotrophic Factor (“MANF”) and is developing MANF-based products as treatments for brain disorders. Amarantus is a Founding Member of the Coalition for Concussion Treatment (#C4CT), a movement initiated in collaboration with Brewer Sports International seeking to raise awareness of new treatments in development for concussions and nervous-system disorders. The Company also owns intellectual property for the diagnosis of Parkinson’s disease (“NuroPro”) and the discovery of neurotrophic factors (“PhenoGuard”). For further information please visit www.Amarantus.com, or connect with the Company on Facebook, LinkedIn, Twitter and Google+.

About TheChairmansBlog.com

TheChairmansBlog.com is an exclusive, online media publication where publicly and privately held firms alike share insights about their companies and industries. TheChairmansBlog.com enables upper tier management to discuss issues that are of importance to their stakeholders, shareholders, and interested parties in an informal environment. www.thechairmansblog.com

 

SOURCE: Amarantus Bioscience Holdings, Inc.

ReleaseID: 413716

  • Latest NewsMore>>

  • Bat Colony Causing Issues for Ft. Hood Workers, Officials Working to Fix Problem

    Bat Colony Causing Issues for Ft. Hood Workers, Officials Working to Fix Problem

    Tuesday, August 26 2014 9:12 PM EDT2014-08-27 01:12:14 GMT
    Dead bat found at Building 4001, picture taken by civilian workerDead bat found at Building 4001, picture taken by civilian worker
    (KCEN) – A bat colony on Fort Hood is causing safety and health concerns among civilian workers at a particular building on post. Officials say while workers may be frustrated, their safety is the number one priority and they're working to fix the problem. Fort Hood's Public Works director Brian Dosa says about six months ago they moved the maintenance workers out of old buildings that will soon be demolished. The crew of about 140 workers was then moved to building 4001. “We knew there had ...More >>
    (KCEN) – A bat colony on Fort Hood is causing safety and health concerns among civilian workers at a particular building on post. Officials say while workers may be frustrated, their safety is the number one priority and they're working to fix the problem. Fort Hood's Public Works director Brian Dosa says about six months ago they moved the maintenance workers out of old buildings that will soon be demolished. The crew of about 140 workers was then moved to building 4001. “We knew there had ...More >>
  • Health Groups Push Stronger E-Cigarette Restrictions, Bans on Indoor 'Vaping'

    Health Groups Push Stronger E-Cigarette Restrictions, Bans on Indoor 'Vaping'

    Tuesday, August 26 2014 6:41 PM EDT2014-08-26 22:41:25 GMT
    (KCEN) -- They're "addicting another generation of smokers," or so says the American Heart Association about e-cigarettes. And now another major health group, the World Health Organization is pushing for further restrictions on the devices.More >>
    (KCEN) -- They're "addicting another generation of smokers," or so says the American Heart Association about e-cigarettes. And now another major health group, the World Health Organization is pushing for further restrictions on the devices.More >>
  • Fire Worries Killeen, Harker Heights Resident

    Fire Worries Killeen, Harker Heights Resident

    Tuesday, August 26 2014 5:41 PM EDT2014-08-26 21:41:16 GMT
    A fire behind a local hospital had some people in Killeen and Harker Heights a little worried Tuesday afternoon..More >>
    A fire behind a local hospital had some people in Killeen and Harker Heights a little worried Tuesday afternoon..More >>
Powered by WorldNow
All content © Copyright 2000 - 2014 WorldNow and KCEN. All Rights Reserved. Users of this site agree to the Terms of Service, Privacy Notice/Your California Privacy Rights, and Ad Choices.